Recent studies have demonstrated that a medication commonly prescribed for type 2 diabetes and obesity, glucagon-like peptide-1 receptor agonists (GLP-1RA), plays a role in facilitating retinal neuroprotection, which, in turn, may prevent glaucoma development and progression
The Microdose GLP-1 Rx Program is priced at $119 to start, followed by $199 per month, which includes medication, if prescribed, and Nooms powerful GLP-1 Companion, providing clinical care, coaching, and a personalized healthy habits program
B12 deficiency prevention during GLP-1 therapy This is the more serious reason for B12 inclusion, and it is one that many patients are not informed about
lower C-rating is acceptable because average current draw is lower than racing
Combination approaches are also gaining traction in clinical development as a potential means to improve efficacy and address risk factors / comorbidities